Similar articles

• Diagnostic dependability of calcitonin assay in family studies for medullary thyroid carcinoma.

  Jackson CE, Tashjian AH Jr, Block MA. Jackson CE, et al. J Lab Clin Med. 1971 Nov;78(5):817-8. J Lab Clin Med. 1971. PMID: 5128860 No abstract available.
• Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.

  Goltzman D, Potts JT Jr, Ridgway RC, Maloof F. Goltzman D, et al. N Engl J Med. 1974 May 9;290(19):1035-9. doi: 10.1056/NEJM197405092901901. N Engl J Med. 1974. PMID: 4207025 No abstract available.
• [Calcitonin as a tumor marker. I. Medullary carcinoma of the thyroid].

  Galán Galán F, Garrido Peralta M. Galán Galán F, et al. Rev Clin Esp. 1982 Apr 15;165(1):5-9. Rev Clin Esp. 1982. PMID: 7122936 Spanish. No abstract available.
• [Medullary carcinoma of the thyroid. New features].

  Alonso Rodríguez C, Pato Castel I. Alonso Rodríguez C, et al. Rev Clin Esp. 1983 Jan 15;168(1):1-8. Rev Clin Esp. 1983. PMID: 6133321 Review. Spanish. No abstract available.
• Management of medullary thyroid carcinomas.

  Hamoir M, Maisin JP, Warnier P, Ketelslegers JM, Rahier J. Hamoir M, et al. Acta Otorhinolaryngol Belg. 1987;41(5):782-92. Acta Otorhinolaryngol Belg. 1987. PMID: 2899945 Review. No abstract available.